ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,964Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 944

$496K Total Retail Price of All Prescriptions

Rank: 216 out of 944

489 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 489 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,684 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 795 739 1 1
LISINOPRIL 643 575 2 3
AMLODIPINE BESYLATE 474 406 3 5
METOPROLOL TARTRATE 424 390 4 8
OMEPRAZOLE 375 299 5 4
METOPROLOL SUCCINATE 372 346 6 14
LEVOTHYROXINE SODIUM 354 335 7 2
HYDROCHLOROTHIAZIDE 340 318 8 9
PRAVASTATIN SODIUM 340 306 8 17
WARFARIN SODIUM 318 295 10 7
LOSARTAN POTASSIUM 262 229 11 16
FUROSEMIDE 255 216 12 6
ATENOLOL 250 229 13 11
POTASSIUM CHLORIDE 210 197 14 15
ALLOPURINOL 200 188 15 22
METFORMIN HCL 188 169 16 12
ISOSORBIDE MONONITRATE ER 174 170 17 52
GABAPENTIN 161 124 18 18
SERTRALINE HCL 153 141 19 23
TAMSULOSIN HCL 144 127 20 27
ADVAIR DISKUS 111 97 21 31
TERAZOSIN HCL 110 85 22 99
ZOLPIDEM TARTRATE 109 97 23 25
ATORVASTATIN CALCIUM 106 104 24 13
HYDROCODONE-ACETAMINOPHEN 103 101 S3 25 10
FLUTICASONE PROPIONATE 102 85 26 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 101 90 27 29
GLIMEPIRIDE 99 98 28 47
LOVASTATIN 96 95 29 26
PAROXETINE HCL 92 85 30 64
TRIAMTERENE-HCTZ 90 80 31 33
NITROSTAT 88 87 32 145
DOXAZOSIN MESYLATE 87 76 33 60
CITALOPRAM HBR 85 63 34 19
CLOPIDOGREL 83 83 35 36
CRESTOR 80 68 36 28
PANTOPRAZOLE SODIUM 72 64 37 34
TRAMADOL HCL 69 67 38 21
PREDNISONE 68 68 39 32
PROAIR HFA 68 37 39 56
LOSARTAN-HYDROCHLOROTHIAZIDE 66 56 41 54
GLIPIZIDE 66 55 41 51
ZETIA 64 64 43 59
SPIRONOLACTONE 63 63 44 44
VENTOLIN HFA 63 61 44 116
SPIRIVA 61 59 46 65
OXYBUTYNIN CHLORIDE 61 61 46 94
PLAVIX 58 58 48 55
LANTUS 57 41 49 46
TRAZODONE HCL 56 36 50 45
ALENDRONATE SODIUM 54 50 51 20
DICYCLOMINE HCL 51 16 52 269
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 19, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.